COST MINIMIZATION ANALYSIS OF TEDIZOLID FOR THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN SUB-STRUCTURE INFECTIONS (ABSSSI) IN GREECE
Author(s)
Insinga R1, Dalakaki E2, Retsa MP2, Karokis A2, Sarpong EM1
1Merck & Co., Inc., Kenilworth, NJ, USA, 2MSD Greece, Athens, Greece
Presentation Documents
OBJECTIVES:
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PIN58
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Infectious Disease (non-vaccine), Sensory System Disorders
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now